You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 684 Assay development and quantitative detection of ADI-001, a CD20-targeted γδ1 CAR T therapy, using AlloCell, a universal assay for monitoring of off-the-shelf allogeneic cell therapies

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
684 Assay development and quantitative detection of ADI-001, a CD20-targeted γδ1 CAR T therapy, using AlloCell, a universal assay for monitoring of off-the-shelf allogeneic cell therapies

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023204016
Dec 20234605
Jan 20242301
Feb 20242201
Mar 20243601
Apr 20242202
May 20243403
Jun 20242002
Jul 20244208
Aug 20241602
Sep 20247606
Oct 20244606
Nov 20243601
Dec 20242608
Jan 20253607
Feb 2025808
Mar 2025003
Apr 2025005
May 2025106
Jun 2025102
Total695093